S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

BCRX BioCryst Pharmaceuticals Inc

7.50

0.11 (1.49%)

Pre Market

Last Updated: 07:56:11

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

BioCryst Pharmaceuticals (NASDAQ:BCRX)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more BioCryst Pharmaceuticals Charts.

BioCryst Pharmaceuticals (NASDAQ:BCRX)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more BioCryst Pharmaceuticals Charts.

BioCryst Pharmaceuticals Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 December 2024 (3 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 December 2024 (3 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 December 2024 (3 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 December 2024 (3 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 December 2024 (3 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 16 December 2024 (4 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 13 December 2024 (7 days ago) • Edgar (US Regulatory)

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Wednesday 4 December 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Monday 2 December 2024 (3 weeks ago) • Edgar (US Regulatory)

BioCryst Launches ORLADEYO® (berotralstat) in Ireland
Monday 18 November 2024 (1 month ago) • GlobeNewswire Inc.

BioCryst to Present at Upcoming Investor Conferences
Wednesday 6 November 2024 (1 month ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 5 November 2024 (1 month ago) • Edgar (US Regulatory)

More BioCryst Pharmaceuticals Inc News Articles

Movement Industries (PK)

BlaqClouds (PK)

Cann American (CE)

Quantum Computing

Accredited Solutions (PK)

Ubiquitech Software (PK)

Enanta Pharmaceuticals

NioCorp Developments

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions